IP Verse

Laboratoire Français Du Fractionnement Et Des Biotechnologies patent opposition analysis

Latest patents of Laboratoire Français Du Fractionnement Et Des Biotechnologies opposed by its competitors

The following table provides an overview of the latest patents of Laboratoire Français Du Fractionnement Et Des Biotechnologies that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3481415Sep 6, 2023Stable Liquid Fibrinogen3
EP3806891Aug 2, 2023Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific Antibody1
EP2651978Jan 12, 2022Use Of An Antibody Directed Against A Membrane Protein1
EP3390452May 26, 2021New Use Of An Anti-Cd303 Transmembrane Protein Antibody1
EP3277723Jun 17, 2020Cell Line Overexpressing Human Cd303 Antigen1
EP3116527Sep 4, 2019Method For Preparing Human Plasma Proteins2
EP2345425Jul 11, 2018Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs2

Top competitors of Laboratoire Français Du Fractionnement Et Des Biotechnologies